Condition
Peptides
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07528469Not ApplicableRecruiting
The Effects of PeptiStrong and Whey on Muscle Function In Older Adults
NCT07451769Not ApplicableNot Yet Recruiting
Selective Activation of the Adrenomedullin Receptors in Migraine
NCT07340775Not ApplicableNot Yet Recruiting
Hypersensitivity to Amylin in Post-Traumatic Headache
NCT07340788Not ApplicableNot Yet Recruiting
Amylin-Induced Migraine Attacks Without Aura
Showing all 4 trials